Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Spectrum Pharmaceuticals Inc (NASDAQ:SPPI)

9.37
Delayed Data
As of Aug 21
 -0.03 / -0.32%
Today’s Change
3.21
Today|||52-Week Range
9.70
+111.51%
Year-to-Date
Spectrum (SPPI) Initiates Phase II Study for Cancer Drug
Aug 16 / Zacks.com - Paid Partner Content
Ligand (LGND) Q2 Earnings & Revenues Top, 2017 View Raised
Aug 08 / Zacks.com - Paid Partner Content